309 related articles for article (PubMed ID: 25444344)
21. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
[TBL] [Abstract][Full Text] [Related]
22. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
Stepien KE; Han DP; Schell J; Godara P; Rha J; Carroll J
Trans Am Ophthalmol Soc; 2009 Dec; 107():28-33. PubMed ID: 20126479
[TBL] [Abstract][Full Text] [Related]
23. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
24. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
Forte R; Haulani H; Dyrda A; Jürgens I
Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
[TBL] [Abstract][Full Text] [Related]
25. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
Jayakar G; De Silva T; Cukras CA
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
[TBL] [Abstract][Full Text] [Related]
26. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
27. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
28. Hydroxychloroquine screening practice patterns within a large multispecialty ophthalmic practice.
Au A; Parikh V; Modi YS; Ehlers JP; Schachat AP; Singh RP
Am J Ophthalmol; 2015 Sep; 160(3):561-568.e2. PubMed ID: 26116260
[TBL] [Abstract][Full Text] [Related]
29. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
Missner S; Kellner U
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
[TBL] [Abstract][Full Text] [Related]
30. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
31. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
[TBL] [Abstract][Full Text] [Related]
32. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
33. SEQUENTIAL RETINAL THICKNESS ANALYSIS SHOWS HYDROXYCHLOROQUINE DAMAGE BEFORE OTHER SCREENING TECHNIQUES.
Marmor MF; Durbin M; de Sisternes L; Pham BH
Retin Cases Brief Rep; 2021 May; 15(3):185-196. PubMed ID: 33394957
[TBL] [Abstract][Full Text] [Related]
34. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.
Lai TY; Ngai JW; Chan WM; Lam DS
Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707
[TBL] [Abstract][Full Text] [Related]
35. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
36. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity.
Tsang A; Kanda P; Gottlieb C; Virgili G; Kantungane L; Coupland S
Doc Ophthalmol; 2022 Apr; 144(2):117-124. PubMed ID: 34762206
[TBL] [Abstract][Full Text] [Related]
37. Hydroxychloroquine retinopathy: an emerging problem.
Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
[TBL] [Abstract][Full Text] [Related]
38. Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus.
Piggott KD; Apte R
Indian J Ophthalmol; 2018 Dec; 66(12):1861-1862. PubMed ID: 30451203
[No Abstract] [Full Text] [Related]
39. Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.
Jivrajka RV; Genead MA; McAnany JJ; Chow CC; Mieler WF
Eye (Lond); 2013 Sep; 27(9):1044-52. PubMed ID: 23764990
[TBL] [Abstract][Full Text] [Related]
40. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
